AU2006205696C1 - IL-10 related peptides for wound healing - Google Patents

IL-10 related peptides for wound healing Download PDF

Info

Publication number
AU2006205696C1
AU2006205696C1 AU2006205696A AU2006205696A AU2006205696C1 AU 2006205696 C1 AU2006205696 C1 AU 2006205696C1 AU 2006205696 A AU2006205696 A AU 2006205696A AU 2006205696 A AU2006205696 A AU 2006205696A AU 2006205696 C1 AU2006205696 C1 AU 2006205696C1
Authority
AU
Australia
Prior art keywords
wound
scar
wounds
peptide
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2006205696A
Other languages
English (en)
Other versions
AU2006205696A1 (en
AU2006205696B2 (en
Inventor
Amanda Deakin
Mark W. J. Ferguson
Sharon O'kane
Nick Occleston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Renovo Ltd
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Ltd filed Critical Renovo Ltd
Publication of AU2006205696A1 publication Critical patent/AU2006205696A1/en
Publication of AU2006205696B2 publication Critical patent/AU2006205696B2/en
Application granted granted Critical
Publication of AU2006205696C1 publication Critical patent/AU2006205696C1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • A61K38/2066IL-10
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2006205696A 2005-01-13 2006-01-06 IL-10 related peptides for wound healing Ceased AU2006205696C1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0500643.2 2005-01-13
GBGB0500643.2A GB0500643D0 (en) 2005-01-13 2005-01-13 Medicaments
PCT/GB2006/000051 WO2006075138A2 (en) 2005-01-13 2006-01-06 Il-10 related peptides for wound healing

Publications (3)

Publication Number Publication Date
AU2006205696A1 AU2006205696A1 (en) 2006-07-20
AU2006205696B2 AU2006205696B2 (en) 2011-09-01
AU2006205696C1 true AU2006205696C1 (en) 2012-01-19

Family

ID=34224534

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006205696A Ceased AU2006205696C1 (en) 2005-01-13 2006-01-06 IL-10 related peptides for wound healing

Country Status (7)

Country Link
US (3) US20080139478A1 (https=)
EP (2) EP2332566A1 (https=)
JP (2) JP2008526935A (https=)
AU (1) AU2006205696C1 (https=)
CA (1) CA2594798A1 (https=)
GB (1) GB0500643D0 (https=)
WO (1) WO2006075138A2 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0500643D0 (en) 2005-01-13 2005-02-23 Renovo Ltd Medicaments
AU2007319811A1 (en) * 2006-11-15 2008-05-22 Coda Therapeutics, Inc. Improved methods and compositions for wound healing
CA2767132C (en) 2009-07-06 2017-06-20 Astrazeneca Ab Intermediates and processes for the preparation of 4-(acetylamino))-3-[(4-chloro-phenyl)thio]-2-methyl-1h-indole-1-acetic acid
WO2012135842A2 (en) * 2011-03-31 2012-10-04 President And Fellows Of Harvard College A unique population of regulatory t cells that regulate tissue regeneration and wound healing
BR112015022747B1 (pt) * 2013-03-14 2020-10-13 3-D Matrix, Ltd kit para prevenção de estenose e uso de um peptídeo de automontagem
EP2986306A4 (en) 2013-04-18 2016-12-07 Armo Biosciences Inc METHOD FOR USE OF INTERLEUKIN-10 FOR THE TREATMENT OF ILLNESSES AND SUFFERING
ES2688206T3 (es) 2013-06-17 2018-10-31 Armo Biosciences, Inc. Procedimiento de evaluación de la identidad y la estabilidad de proteínas
US10098929B2 (en) 2013-08-02 2018-10-16 Children's Hospital Medical Center Method of reducing scar formation in healing of dermal wounds by administering interleukin-10 and hyaluronan
CN105658232A (zh) 2013-08-30 2016-06-08 阿尔莫生物科技股份有限公司 使用白细胞介素-10治疗疾病和病症的方法
EP3068425B1 (en) 2013-11-11 2021-01-27 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
WO2015187295A2 (en) 2014-06-02 2015-12-10 Armo Biosciences, Inc. Methods of lowering serum cholesterol
WO2016060996A2 (en) 2014-10-14 2016-04-21 Armo Biosciences, Inc. Interleukin-15 compositions and uses thereof
AU2015336101A1 (en) 2014-10-22 2017-04-20 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
US10618970B2 (en) 2015-02-03 2020-04-14 Armo Biosciences, Inc. Method of treating cancer with IL-10 and antibodies that induce ADCC
CA2986755A1 (en) 2015-05-28 2016-12-01 Armo Biosciences, Inc. Pegylated interleukin-10 for use in treating cancer
US10398761B2 (en) 2015-08-25 2019-09-03 Armo Biosciences, Inc. Methods of using combinations of PEG-IL-10 and IL-15 for treating cancers

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020128447A1 (en) * 1995-08-09 2002-09-12 Renovo Limited Pharmaceutical composition containing IL-10

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6217857B1 (en) * 1989-06-28 2001-04-17 Schering Corporation Cytokine synthesis inhibitory factor (IL-10) and pharmaceutical compositions thereof
US6159937A (en) * 1994-07-05 2000-12-12 Steeno Research Group A/S Immunomodulators
AU4385696A (en) * 1996-01-18 1997-08-11 Christian Gronhoj Larsen Synthetic il-10 analogues
GB0500643D0 (en) 2005-01-13 2005-02-23 Renovo Ltd Medicaments

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020128447A1 (en) * 1995-08-09 2002-09-12 Renovo Limited Pharmaceutical composition containing IL-10

Also Published As

Publication number Publication date
US20080139478A1 (en) 2008-06-12
EP2332566A1 (en) 2011-06-15
US20150218222A1 (en) 2015-08-06
WO2006075138A2 (en) 2006-07-20
AU2006205696A1 (en) 2006-07-20
JP2012211185A (ja) 2012-11-01
JP2008526935A (ja) 2008-07-24
CA2594798A1 (en) 2006-07-20
HK1105366A1 (en) 2008-02-15
EP1858544A2 (en) 2007-11-28
AU2006205696B2 (en) 2011-09-01
WO2006075138A3 (en) 2006-10-19
GB0500643D0 (en) 2005-02-23
EP1858544B1 (en) 2014-03-05
US20120238505A1 (en) 2012-09-20

Similar Documents

Publication Publication Date Title
US20150218222A1 (en) Medicaments
EP2359844A2 (en) Medicaments and proteins based on TGF-beta monomers for the treatment of wounds
WO1998036061A2 (en) Reducing fibrosis and/or scarring by inhibiting interleukin-6 receptor-mediated activity
EP0941108B1 (en) Wound healing and treatment of fibrosis
US20110212897A1 (en) Wnt3a for inhibition of scarring
BRPI0708785A2 (pt) proteÍnas, Ácidos nuclÉicos e medicamentos
US20100137201A1 (en) Medicaments
US20100261659A1 (en) Secreted frizzled related protein 3 for use in the inhibition of scarring
HK1105366B (en) Il-10 related peptides for wound healing
HK1158509A (en) Il-10 related peptides for wound healing
JP2010535184A (ja) 非眼瘢痕の抑制に使用できる薬剤および方法
HK1025732B (en) Wound healing and treatment of fibrosis

Legal Events

Date Code Title Description
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 12 SEP 2011.

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 12 SEP 2011

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired